Search
Search Constraints
You searched for: Date 2022 Journal ToxiconLimit your search
- 615.9 361
- Toxins -- Periodicals 361
- Venom -- Periodicals 361
- 1, 2, 5-Trithiepane -- Insecticide -- N, N-dimethylaniline -- Saliva -- Toxicity 1
- 3FTx three-finger toxins -- 4N3OBA 4-nitro-3-octanoyloxy-benzoic acid -- ACP acid phosphatase -- ALP alkaline phosphatase -- ALT alanine aminotransferase -- Asp49-PLA2s phospholipases A2 with aspartate in position 49 -- AST aspartate aminotransferase -- BAPNA Nα-Benzoyl-L-arginine 4-nitroanilide hydrochloride -- BthTX-I Lys49-PLA2 isolated from the Bothrops jararacussu venom -- BthTX-II Asp49-PLA2 from the Bothrops jararacussu venom -- CA caffeic acid -- CHA chlorogenic acid -- CK creatine kinase -- CTL type C lectins -- Cys45 cysteine in position 45 -- DLS dynamic light scattering -- DMH minimum hemorrhagic doses -- DPTP diheptanoyl thiophosphocholine -- HPLC high performance liquid chromatography -- FACITs fibrillar-associated collagens with interrupted triple helices -- FTIR fourier-transform infrared spectroscopy -- GA gallic acid -- Gln11 glutamine in position 11 -- Gly15 glycine in position 15 -- GROMACS Groningen Machine for Chemical Simulation -- HC hemorrhagic complex -- HCh hydrophobic channel -- HMBA 2-hydroxy-4-methoxy benzoic acid -- HPGP 1-hex-adecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphogly-cerol -- HUVEC human umbilical vein endothelial -- IC50 half maximal inhibitory concentration -- i.p. intraperitoneal route -- i.m. intramuscular route -- i.v. intravenous route -- LAAO L-amino acid oxidase -- LDH lactate dehydrogenase -- Leu10 leucine in position 10 -- Lys49-PLA2 phospholipases A2 with lysine in position 49 -- Lys7 lysine in position 7 -- MDiS membrane rupture site -- MDoS membrane docking site -- MjTX-II myotoxin isolated from Bothrops moojeni venom -- MOE 2004.05 molecular operating environment -- pCA p-coumaric acid -- PCT triacontyl p-coumarate -- pH hydrogen potential -- Phe3 phenylalanine in position 3 -- PLA2s phospholipases A2s -- Pro123 proline in position 123 -- PrTX-I Lys49-PLA2 isolated from Bothrops pirajai venom -- QSAR quantitative structure–activity relationship -- RA rosmarinic acid -- s.c. subcutaneous route -- SAXS small angle X-ray scattering -- SDS-PAGE sodium dodecyl sulphate–polyacrylamide gel electrophoresis -- SPR surface plasmon resonance -- SVMPs metalloproteinases -- SVSPs serine proteases -- TBAPs thiobarbituric acid products -- TEM transmission electron microscopy -- TLC thin layer chromatography -- Trp 31 tryptophan in position 31 -- VA vanillic acid -- w: w weight: weight -- γ-GT γ-glutamyl transferase 1
- 4-(methylthio)butyl isocyanate -- Erucin -- Pharmacokinetics -- Ex vivo permeation -- SGOT -- Hepatotoxicity 1
- ACE angiotensin converting enzyme -- AspP aspartic protease -- BAEE benzoylarginine ethyl ester -- BNP B-type natriuretic peptide -- BPP bradykinin potentiating peptides -- CNP C-type natriuretic peptide -- CRISP cysteine rich secretory protein -- CTL C-type lectin/snaclec -- Hyal hyaluronidase -- KUN Kunitz type proteinase inhibitor -- LAAO L-amino acid oxidase -- MALDI-TOF MS matrix-assisted laser desorption ionization/time of flight mass spectrometry -- 5′-NT 5′- nucleotidase -- NGF nerve growth factor -- NP natriuretic peptide -- PDE phosphodiesterase -- PLA2 phospholipase A2 -- PLB phospholipase B -- Pro-Phe-Arg-MCA Pro-Phe-Arg-4-methylcoumarinyl-7-amide -- QC glutaminyl-peptide cyclotransferase -- SVMP snake venom metalloproteinase -- SVSP snake venom serine proteinase -- TAME tosylarginine methyl ester -- VBFXAE V. berus factor X activating enzyme -- VEGF vascular endothelial growth factor 1
- ACN Acetonitrile -- CRISP Cysteine-rich secretory protein -- CTL C-type lectins -- DTT Dithiothreitol -- ELISA Enzyme linked immuno sorbent assay -- HYA Hyaluronidase -- IAA Iodoacetamide -- LAAO L-amino acid oxidase -- LC-MS/MS Liquid chromatography-mass spectrometry/mass spectrometry -- MCD Minimum coagulant dose -- MS Mass spectrometry -- NOBA 4-nitro-3-octanoyloxy-benzoic acid -- NT Nucleotidases -- OPD o-Phenylenediamine -- PBS Phosphate-buffered saline -- PLA2 Phospholipase A2 -- PLB Phospholipase B -- RP–HPLC Reversed-phase high-performance liquid chromatography -- SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis -- SVMP Snake venom metalloproteinase -- SVSP Snake venom serine proteinase -- TBS Tris-buffered saline -- TCA Trichloroacetic acid -- TFA Trifluoroacetic acid -- VEGF Vascular endothelial growth factors 1
- AI artificial intelligence -- AIIMS All India Institute of Medical Science -- ɣ-GT gamma glutamyl transferase -- GI gastrointestinal irritants -- HBDH hydroxybutyrate dehydrogenase -- LSD lysergic acid diethylamide -- MFH N-methyl-N-formylhydrazine -- MMH monomethyl-hydrazine -- NPIC National Poison Information Center -- NTC sodium taurocholate co-transporting polypeptide -- SGOT serum glutamic-oxaloacetic transaminase -- SGPT serum glutamic pyruvic transaminase -- WHO World Health Organization 1
- AKI acute kidney injury -- ALT alanine aminotransferase -- AST aspartate aminotransferase -- CA3 carbonic anhydrase 3 -- CK creatine kinase -- FC fold change -- GO Gene Ontology -- HPLC-ESI-MS/MS ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry -- KDIGO Kidney Disease Improving Global Outcome -- TCEP tris (2-carboxyethyl) phosphine -- CAA chloroacetamide -- SDC sodium deoxycholate -- KEGG Kyoto Encyclopedia of Genes and Genomes -- LDH lactate dehydrogenase -- MYL3 myosin light chain 3 -- NAKI without AKI group -- OPLS-DA orthogonal partial least square discriminant analysis -- PC phosphatidylcholine -- PE phosphatidylethanolamine -- PLA phospholipase A1 -- RBCs red blood cells -- Scr serum creatinine -- SM sphingomyelins 1